XENETIC BIOSCIENCES, INC. Deferred Tax Liabilities, Leasing Arrangements
XENETIC BIOSCIENCES, INC. (XBIO) had Deferred Tax Liabilities, Leasing Arrangements of $0 as of 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesLeasingArrangements · last filed 2024-03-21
- 2023-12-31: Deferred Tax Liabilities, Leasing Arrangements $0.00.
- 2022-12-31: Deferred Tax Liabilities, Leasing Arrangements $0.00.
- 2021-12-31: Deferred Tax Liabilities, Leasing Arrangements $7.39K.
- 2020-12-31: Deferred Tax Liabilities, Leasing Arrangements $17.08K.
| Period end | Deferred Tax Liabilities, Leasing Arrangements |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-21 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-21 |
| 2021-12-31 | $7.39K 10-K · filed 2023-03-22 |
| 2020-12-31 | $17.08K 10-K · filed 2022-03-22 |
| 2019-12-31 | $5.47K 10-K · filed 2021-03-16 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |